Effectiveness and tolerability of early initiation of combined lipid-lowering therapy included simvastatin and fenofibrate vs simvastatin alone in patients with acute coronary syndrome and type 2 diabetes mellitus with hypertriglyceridemia. Ukrainian Journal of Cardiology, [S. l.], v. 27, n. 2, p. 34–45, 2020. DOI: 10.31928/1608-635X-2020.2.3445. Disponível em: https://ucardioj.com.ua/index.php/UJC/article/view/213.. Acesso em: 3 may. 2024.